{"database": "lobbying", "table": "lobbying_activities", "rows": [[3231946, "d8143dc3-1f32-4e0c-82e5-b4d6709c0fff", "Q3", "MAGILL ASSOCIATES, LLC", 401103511, "THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES", 2024, "third_quarter", "BUD", "FY 2025 appropriations for the development of a synthetic vaccine", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-10-02T11:25:44-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3231946"], "units": {}, "query_ms": 16.220855060964823, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}